These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19426728)

  • 21. Overproduction of stable ornithine decarboxylase and antizyme in the difluoromethylornithine-resistant cell line DH23b.
    Mitchell JL; Choe CY; Judd GG; Daghfal DJ; Kurzeja RJ; Leyser A
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):811-6. PubMed ID: 8760367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Destabilization of ornithine decarboxylase by transfected antizyme gene expression in hepatoma tissue culture cells.
    Murakami Y; Matsufuji S; Miyazaki Y; Hayashi S
    J Biol Chem; 1992 Jul; 267(19):13138-41. PubMed ID: 1618815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular localization of ornithine decarboxylase and its regulatory protein, antizyme-1.
    Schipper RG; Cuijpers VM; De Groot LH; Thio M; Verhofstad AA
    J Histochem Cytochem; 2004 Oct; 52(10):1259-66. PubMed ID: 15385572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic analysis of polyamine-related genes and polyamine levels in placenta, yolk sac and fetus during the second half of mouse pregnancy.
    Lopez-Garcia C; Lopez-Contreras AJ; Cremades A; Castells MT; Peñafiel R
    Placenta; 2009 Mar; 30(3):241-9. PubMed ID: 19131104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data.
    Cohavi O; Tobi D; Schreiber G
    J Mol Biol; 2009 Jul; 390(3):503-15. PubMed ID: 19465028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of ornithine decarboxylase-antizyme complex in HMOA cells.
    Murakami Y; Fujita K; Kameji T; Hayashi S
    Biochem J; 1985 Feb; 225(3):689-97. PubMed ID: 3919709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular polyamines.
    Petros LM; Graminski GF; Robinson S; Burns MR; Kisiel N; Gesteland RF; Atkins JF; Kramer DL; Howard MT; Weeks RS
    J Biochem; 2006 Nov; 140(5):657-66. PubMed ID: 16998202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of ornithine decarboxylase antizyme inhibitor in vivo.
    Tang H; Ariki K; Ohkido M; Murakami Y; Matsufuji S; Li Z; Yamamura K
    Genes Cells; 2009 Jan; 14(1):79-87. PubMed ID: 19077035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antizyme and antizyme inhibitor, a regulatory tango.
    Kahana C
    Cell Mol Life Sci; 2009 Aug; 66(15):2479-88. PubMed ID: 19399584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
    Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
    Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of ODC and its regulatory protein antizyme in the adult rat brain.
    Kilpeläinen P; Rybnikova E; Hietala O; Pelto-Huikko M
    J Neurosci Res; 2000 Dec; 62(5):675-85. PubMed ID: 11104505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs.
    Mitchell JL; Thane TK; Sequeira JM; Marton LJ; Thokala R
    Amino Acids; 2007 Aug; 33(2):291-7. PubMed ID: 17410332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification.
    Mangold U; Hayakawa H; Coughlin M; Münger K; Zetter BR
    Oncogene; 2008 Jan; 27(5):604-13. PubMed ID: 17667942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin.
    Wolf C; Brüss M; Hänisch B; Göthert M; von Kügelgen I; Molderings GJ
    Mol Pharmacol; 2007 Jan; 71(1):276-83. PubMed ID: 17047095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular localization of antizyme inhibitor 2 in mammalian cells: Influence of intrinsic sequences and interaction with antizymes.
    López-Contreras AJ; Sánchez-Laorden BL; Ramos-Molina B; de la Morena ME; Cremades A; Peñafiel R
    J Cell Biochem; 2009 Jul; 107(4):732-40. PubMed ID: 19449338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of antizyme inhibitor 2 in male haploid germinal cells suggests a role in spermiogenesis.
    López-Contreras AJ; Ramos-Molina B; Martínez-de-la-Torre M; Peñafiel-Verdú C; Puelles L; Cremades A; Peñafiel R
    Int J Biochem Cell Biol; 2009 May; 41(5):1070-8. PubMed ID: 18973822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antizyme is necessary for conversion of pancreatic tumor cells into glucagon-producing differentiated cells.
    Suzuki J; Murakami Y; Samejima K; Ohtani KK; Oka T
    Endocr Relat Cancer; 2009 Jun; 16(2):649-59. PubMed ID: 19349429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The velocity of the reaction between ornithine decarboxylase and antizyme highly depends on the presence of salt and temperature.
    Kitani T; Fujisawa H
    Biochem Int; 1985 Mar; 10(3):435-40. PubMed ID: 4015667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naf1alpha is phosphorylated in mitotic phase and required to protect cells against apoptosis.
    Zhang S; Mahalingam M; Tsuchida N
    Biochem Biophys Res Commun; 2008 Mar; 367(2):364-9. PubMed ID: 18167309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase.
    Kanerva K; Mäkitie LT; Pelander A; Heiskala M; Andersson LC
    Biochem J; 2008 Jan; 409(1):187-92. PubMed ID: 17900240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.